Advertisement
Supported by
Under a new governor, it’s hoping to use its status as the most populous state as leverage when it negotiates with drug makers.
By Katie Thomas
While the Agriculture Department continues to inspect domestic meat and poultry, the F.D.A. has reduced inspections of fruits, vegetables and other foods.
By Sheila Kaplan
Gov. Andrew M. Cuomo appeared with Hillary Clinton to promise to strengthen reproductive rights within 30 days of the new legislative session.
By Vivian Wang
AstraZeneca has hired Dr. José Baselga, the former chief medical officer at Memorial Sloan Kettering, to lead its cancer research unit.
By Katie Thomas and Charles Ornstein
The Undiagnosed Diseases Network takes on the toughest cases, patients whose symptoms have defied explanation.
By Gina Kolata
Readers of the New York Times Magazine article about the Daileys, “Lost in the Storm,” found Wayne on social media and reached out in droves.
By Sheri Fink
Some hospital executives and cancer researchers sit on the boards of publicly traded companies, raising questions about whether their dual roles create a conflict of interest.
End-of-life spending may seem wasteful, but it turns out it’s hard to predict when someone will die.
By Austin Frakt
A federal judge overseeing the merger settlement wants the combined companies to keep some operations separate while he examines the $69 billion deal.
By Emily Baumgaertner
Legal scholars on opposite sides of previous Obamacare court decisions find the legal argument in this one shaky.
By Jan Hoffman, Robert Pear and Adam Liptak
